MRI Interventions Enters At-The-Market Equity Offering Sales Agreement

On November 7, 2024, MRI Interventions (OTCMKTS: MRIC) announced that it has entered into an At-The-Market Equity Offering Sales Agreement with Stifel, Nicolaus & Company, Incorporated. The Company aims to sell shares of its common stock, par value $0.01 per share, with an aggregate sales value of up to $50 million through this agreement. According […]

Leave a Reply

Your email address will not be published.

Previous post SAB Biotherapeutics (NASDAQ:SABS) Posts Earnings Results, Misses Estimates By $0.05 EPS
Next post Wedbush Reaffirms “Neutral” Rating for Clear Secure (NYSE:YOU)